InnoCare Pharma Limited (INCPF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate InnoCare Pharma Limited's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
30.69
Moderate
WeakModerateStrong
P/B Ratio
2.52
Strong
WeakModerateStrong
Earnings Yield
3.21%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
8.10%
Weak
WeakModerateStrong
Operating Margin
19.18%
Moderate
WeakModerateStrong
Net Profit Margin
27.24%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
127.62%
Strong
WeakModerateStrong
Net Income Growth
242.04%
Strong
WeakModerateStrong
EPS Growth
238.46%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
5.83
Strong
WeakModerateStrong
Quick Ratio
5.71
Strong
WeakModerateStrong
Asset Turnover
0.21x
Weak
WeakModerateStrong
Inventory Turnover
1.75x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.67%
Weak
WeakModerateStrong
EV / Free Cash Flow
107.07x
Weak
WeakModerateStrong
Net Debt / EBITDA
-9.83x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.450
Strong
WeakModerateStrong
Return on Invested Capital
4.46%
Weak
WeakModerateStrong
Cash Conversion Cycle
53.94 days
Weak
WeakModerateStrong
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for INCPF.
View Financial Statements